Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • U S STEM CELL INC COM USD0.001 News

    -   $ 0,00% +0,00 $
    In : -    € | 16.04.24 17:38:43 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    ISIN: US90350U1007
    US-Symbol: USRM
    Typ: Aktie

    U S STEM CELL INC COM USD0.001 News

    01.09.22 - ACCESSWIRE
    Court Reports Favorable Judgment in California Stem Cell Case
    SUNRISE, FL / ACCESSWIRE / September 1, 2022 / U.S. Stem Cell, Inc. (OTC:USRM), a leader in the development of proprietary, physician-​based stem cell therapies and novel ...
    09.03.22 - ACCESSWIRE
    Mark Borman Appointed Chairman of the Board of USRM
    SUNRISE, FL / ACCESSWIRE / March 9, 2022 / U.S. Stem Cell, Inc. (OTC PINK:USRM), a leader in the development of proprietary, physician-​based stem cell therapies and novel ...
    18.10.21 - ACCESSWIRE
    USRM to Focus on Animal Health and Lead Pet-Care Innovation
    SUNRISE, FL / ACCESSWIRE / October 18, 2021 / U.S. Stem Cell, Inc. (OTC PINK:USRM), a leader in the development of proprietary, physician-​based stem cell therapies and novel ...
    08.06.21 - ACCESSWIRE
    US Stem Cell Inc Reports Legal Appeal Results and Company Direction
    SUNRISE, FL / ACCESSWIRE / June 8, 2021 / U.S. Stem Cell, Inc. (OTC:USRM), a corporation that has historically focused on the regenerative medicine / cellular therapy industry ...
    23.02.21 - ACCESSWIRE
    Northstar Biotech and USRM BOD Members Reinvest in the Company
    SUNRISE, FL / ACCESSWIRE / February 23, 2021 / U.S. Stem Cell, Inc. (OTC PINK:USRM), a leader in the development of proprietary, physician-​based, and novel regenerative ...
    19.01.21 - ACCESSWIRE
    USRM Oral Argument in Appeal from FDA Enforcement Action
    SUNRISE, FL / ACCESSWIRE / January 19, 2021 / U.S. Stem Cell, Inc. (OTC PINK:USRM), a leader in the development of proprietary, physician-​based, and novel regenerative ...
    30.09.20 - ACCESSWIRE
    U.S. Stem Cell Confirms Date for Appeals Court Oral Arguments
    SUNRISE, FL / ACCESSWIRE / September 30, 2020 / U.S. Stem Cell, Inc. (OTC PINK:USRM), a leader in the development of proprietary, physician-​based, and novel regenerative ...
    09.08.19 - PR Newswire
    Corrected: USRM Posts Earnings for Second Quarter 2019
    Corrected: USRM Posts Earnings for Second Quarter 2019 PR Newswire
    07.05.19 - PR Newswire
    USRM Posts Financial Results for First Quarter 2019
    USRM Posts Financial Results for First Quarter 2019 PR Newswire
    26.04.19 - PR Newswire
    Dr. Comella to Present at Paleo f(x) Conference in Austin, Texas
    Dr. Comella to Present at Paleo f(x) Conference in Austin, Texas PR Newswire
    13.03.19 - PR Newswire
    USRM Posts Increase in Revenue and Profit Margin for 2018
    USRM Posts Increase in Revenue and Profit Margin for 2018 PR Newswire
    15.01.19 - PR Newswire
    USRM Chief Science Officer Featured on One Radio Network
    USRM Chief Science Officer Featured on One Radio Network PR Newswire
    09.11.18 - PR Newswire
    Dr. Kristin Comella Featured on Robert Scott Bell Show
    Dr. Kristin Comella Featured on Robert Scott Bell Show USRM Chief Science Officer Discusses Health Freedom Surrounding Autologous Stem Cell Industry PR Newswire
    07.11.18 - PR Newswire
    USRM Posts 25% Nine Month Revenue Increase From 3Q 2017
    USRM Posts 25% Nine Month Revenue Increase From 3Q 2017 Profit Margins Continue to Increase As Costs And Operating Expenses Decrease PR Newswire
    09.10.18 - PR Newswire
    Adipose Stem Cells Demonstrate Effectiveness in Repairing Decubitus Ulcers
    Adipose Stem Cells Demonstrate Effectiveness in Repairing Decubitus Ulcers Paper Published by USRM Chief Science Officer in Journal of Medical Cases PR Newswire
    01.10.18 - PR Newswire
    USRM Chief Science Officer Featured on YourVoice™ America
    USRM Chief Science Officer Featured on YourVoice™ America PR Newswire
    26.09.18 - PR Newswire
    Dr. Kristin Comella Joins Top Docs in Fix for Female Hormones Seminar
    Dr. Kristin Comella Joins Top Docs in Fix for Female Hormones Seminar PR Newswire
    11.09.18 - PR Newswire
    USRM Hires Senior VP of US & International Sales
    USRM Hires Senior VP of US & International Sales Former Abbott Pharmaceuticals, Stem Cell Centers Exec Joins Team PR Newswire
    08.08.18 - PR Newswire
    USRM Posts Profitable Results for Second Quarter 2018
    USRM Posts Profitable Results for Second Quarter 2018 Continues to Post Increases in Revenue for Second Straight Year PR Newswire
    10.07.18 - PR Newswire
    Stem Cells Shows Promise For Repairing Torn Meniscus
    Stem Cells Shows Promise For Repairing Torn Meniscus USRM Chief Science Officer Publishes Findings in Peer-​Reviewed Scientific Literature PR Newswire

    Newssuche

    Videos

    newspaper
    09:30 Uhr
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »